Company Filing History:
Years Active: 2019-2021
Title: Beata Nowicka-Sans: Innovator in HIV Research
Introduction
Beata Nowicka-Sans is a prominent inventor based in Wallingford, CT (US). She has made significant contributions to the field of antiviral research, particularly in the development of compounds aimed at treating HIV and AIDS. With a total of two patents to her name, her work is recognized for its potential impact on public health.
Latest Patents
Her latest patents include C-3 and C-17 modified triterpenoids as HIV-1 inhibitors. These patents detail compounds that possess drug and bio-affecting properties, along with their pharmaceutical compositions and methods of use. Specifically, her research focuses on betulinic acid derivatives that exhibit unique antiviral activity, serving as HIV maturation inhibitors. These compounds are represented by specific formulas and are deemed useful for the treatment of HIV and AIDS.
Career Highlights
Beata Nowicka-Sans is currently associated with ViiV Healthcare UK (No. 5) Limited, where she continues her innovative work in antiviral research. Her career is marked by a commitment to developing effective treatments for viral infections, particularly those affecting vulnerable populations.
Collaborations
Some of her notable coworkers include Jie Chen and Yan Chen, who contribute to her research efforts and collaborative projects.
Conclusion
Beata Nowicka-Sans stands out as a dedicated inventor in the field of HIV research, with her patents reflecting her innovative approach to combating viral infections. Her work has the potential to make a significant difference in the lives of those affected by HIV and AIDS.